Vaccine efficacy against nonhospitalized dengue, by serostatus at vaccination.

Vaccine efficacy against nonhospitalized dengue, by serostatus at vaccination.

<p><b>(A)</b> Seronegative at vaccination; <b>(B)</b> seropositive at vaccination. CI, confidence interval.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Jing Shen (308587) (author)
مؤلفون آخرون:	Elizaveta Kharitonova (21560627) (author), Anna Tytula (10660201) (author), Justyna Zawieja (21560630) (author), Samuel Aballea (776714) (author), Shibadas Biswal (19470227) (author), Mayuri Sharma (20761568) (author), Supattra Rungmaitree (12563948) (author), Rosarin Sruamsiri (687533) (author), Derek Wallace (5818994) (author), Riona Hanley (14279398) (author)
منشور في:	2025
الموضوعات:	Medicine Biotechnology Cancer Science Policy Infectious Diseases Computational Biology sensitivity analyses demonstrated national immunization program 47 %&# 8722 346 &# 160 thai dengue epidemiology significant public health new dengue vaccine dengue natural history strategy prevented 87 modeling case study economic burden caused 10 additional catch greatest impact observed xlink "> dengue optimal cohort age dynamic transmission model dengue vaccine tak 415 fewer dalys public health impact xlink "> tak different vaccination strategies thailand </ p xlink "> negative health vaccination strategies study assesses strategy resulted economic impacts adding catch vaccination impact vector populations using thailand symptomatic cases specific infections simplifications made prevent 44 main limitations key elements important measure adjusted life 715 dalys 4 serotype 301 trial
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!